Skip to main content
OpenTrials

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,219 public trials 1,011 recruiting studies
Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

Bortezomib, Paclitaxel, Carboplatin and Radiation Therapy for Non-Small Cell Lung Cancer

NCT00093756

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Saint Francis Hospital and Medical Center Hartford, Connecticut, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Rush - Copley Medical Center Aurora, Illinois, United States
View all 143 locations
View Trial Details
Completed

Inositol in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia

NCT00783705

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • Albuquerque Veterans Administration Medical Center Albuquerque, New Mexico, United States
  • BCCA-Vancouver Cancer Centre Vancouver, British Columbia, Canada
View Trial Details
Completed

NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma

NCT00667082

Conditions
Blood Protein Disorders, Bronchial Neoplasms, Carcinoma, Bronchogenic, +40 more
Locations
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
  • The Queen Elizabeth Hospital Woodville South, South Australia, Australia
  • Sir Charles Gairdner Hospital and University of Western Australia Nedlands, Western Australia, Australia
View Trial Details
Completed

A Phase I Study Of Pazopanib With Either Erlotinib Or Pemetrexed In Patients With Advanced Solid Tumors

NCT00619424

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • GSK Investigational Site Aurora, Colorado, United States
  • GSK Investigational Site Buffalo, New York, United States
  • GSK Investigational Site Nashville, Tennessee, United States
  • GSK Investigational Site Orbassano (TO), Piedmont, Italy
View Trial Details
Completed

A Phase II Trial of Lapatinib (TYKERB) + Pemetrexed (ALIMTA) in Advanced Non Small Cell Lung Cancer With an Initial Dose Finding Phase

NCT00528281

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • GSK Investigational Site Heidelberg, Baden-Wurttemberg, Germany
  • GSK Investigational Site Großhansdorf, Schleswig-Holstein, Germany
  • GSK Investigational Site Orbassano (TO), Piedmont, Italy
  • GSK Investigational Site Poznan, Poland
View Trial Details

Related conditions